| Protocol No. | Title | Status |
| 05-0226-04 | Arizona Lymphoid Tissue and Blood Repository (ALTBR) | Open |
| 05-0303-04 | Phase II Trial of Yttrium-90-Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin's Lymphoma | Open |
| 06-0166-04 | Expression and Role of Pro-IL-16 in T-Cell Malignancies | Open |
| 08-1071-04 | A Phase II, Open-Label Study of Bortezomib (Velcade), Cladribine and Rituximab (VCR) in Advanced, Newly Diagnosed and Relapsed/Refractory Mantle Cell and Indolent Lymphomas (Protocol UACC/UMass) | Open |
| 09-0679-04 | A Phase II Study Of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) For Treatment Of Hematologic Malignancies And Hematopoietic Failure States | Open |
| 09-0967-04 | Lymphoma Outcomes and Epidemiological Database | Open |
| 10-0858-04 | S0806 A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) | Open |
| 11-0642-04 | S1001 “A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL) | Open |
| 11-0931-04 | S1108 A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237, in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma” | Open |
| 12-0288-04 | A Phase II Exploratory Study of PXD101 Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma (Stage 1) | Open |
| 20092131 | Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (COMPLETE) | Open |
| 20110910 | A Multicenter Phase 1-2 Study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma Treated with Rituximab and Vincristine | Open |
| 20110931 | Phase 1b, Escalating Dose Study of AVL-292, a Bruton’s Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects with Relapsed and/or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom’s Macroglobulinemia | Open |
| NMDP2011-0264 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications, version 3.0 | Open |